Evidence map›Paper›PMID 30441874›Full record

ArticleNon-coding RNA2018

lncRNA Expression after Irradiation and Chemoexposure of HNSCC Cell Lines.

Kacper Guglas, Tomasz Kolenda, Anna Teresiak, Magda Kopczyńska, Izabela Łasińska, Jacek Mackiewicz, Andrzej Mackiewicz, Katarzyna Lamperska

Open access · goldAbstract read
In one paragraph

Article in Non-coding RNA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Midsize noncoding RNAs in cancers: a new division that clarifies the world of noncoding RNA or an unnecessary chaos?Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kacper GuglasLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznan, Poland. kacper.guglas@gmail.com.
Tomasz KolendaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznan, Poland. kolenda.tomek@gmail.com.
Anna TeresiakLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznan, Poland. anna.teresiak@wco.pl.
Magda KopczyńskaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznan, Poland. mg.kopczynska@gmail.com.
Izabela ŁasińskaDepartment of Medical and Experimental Oncology, Heliodor Swiecicki Clinical Hospital, University of Medical Sciences, 60-355 Poznan, Poland. lasinska.izabela@spsk2.pl.
Jacek MackiewiczDepartment of Medical and Experimental Oncology, Heliodor Swiecicki Clinical Hospital, University of Medical Sciences, 60-355 Poznan, Poland. jmackiewicz@ump.edu.pl.
Andrzej MackiewiczChair of Medical Biotechnology, Poznan University of Medical Sciences, 61-701 Poznan, Poland. andrzej.mackiewicz@wco.pl.ORCID 0000-0001-5574-6609
Katarzyna LamperskaLaboratory of Cancer Genetics, Greater Poland Cancer Centre, 61-866 Poznan, Poland. kasialam@o2.pl.
Poznan University of Medical Sciences · PLGreater Poland Cancer Center · PLHeliodor Swiecicki Clinical Hospital · PL

Funding

Greater Poland Cancer Centre 13/2016 (128)Greater Poland Cancer Centre 21/2015 (113)Narodowe Centrum Nauki 2016/21/B/NZ7/01773
6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cause of cancer mortality in the world. To improve the quality of diagnostics and patients' treatment, new and effective biomarkers are needed. Recent studies have shown that the expression level of different types of long non-coding RNAs (lncRNAs) is dysregulated in HNSCC and correlates with many biological processes. In this study, the response of lncRNAs in HNSCC cell lines after exposure to irradiation and cytotoxic drugs was examined. The SCC-040, SCC-25, FaDu, and Cal27 cell lines were treated with different radiation doses as well as exposed to cisplatin and doxorubicin. The expression changes of lncRNAs after exposure to these agents were checked by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Target prediction was performed using available online tools and classified into specific biological processes and cellular pathways. The results indicated that the irradiation, as well as chemoexposure, causes changes in lncRNA expression and the effect depends on the cell line, type of agents as well as their dose. After irradiation using the dose of 5 Gy significant dysregulation of 4 lncRNAs, 10 Gy-5 lncRNAs, and 20 Gy-3 lncRNAs, respectively, were observed in all cell lines. Only lncRNAs Zfhx2as was down-regulated in all cell lines independently of the dose used. After cisplatin exposure, 14 lncRNAs showed lower and only two higher expressions. Doxorubicin resulted in lower expressions of eight and increased four of lncRNAs. Common effects of cytotoxic drugs were observed in the case of antiPEG11, BACE1AS, PCGEM1, and ST7OT. Analysis of the predicted targets for dysregulated lncRNAs indicated that they are involved in important biological processes, regulating cellular pathways connected with direct response to irradiation or chemoexposure, cellular phenotype, cancer initiating cells, and angiogenesis. Both irradiation and chemoexposure caused specific changes in lncRNAs expression. However, the common effect is potentially important for cellular response to the stress and survival. Further study will show if lncRNAs are useful tools in patients' treatment monitoring.

Indexed as

cellular stresschemoresistancehead and neck cancerslong non-coding RNA (lncRNA)radioresistance

Identifiers

PMID30441874
PMCPMC6315432
OpenAlexW2900987074

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.